One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Compass Diversified logo
Compass Diversified CODI
$ 10.28 -0.77%
report update icon

Quarterly report 2026-Q2
added 08-10-2026

Compass Diversified Financial Ratios 2025-2008 | CODI

Brief overview of Compass Diversified's valuation multiples

This overview follows the five latest available observations from 2017 through 2023.

The current valuation set is P/E 15.61x (median 36.27x), EV/EBITDA 15.32x (median 34.04x), P/S 1.05x (median 2.89x). The current ratio basket stands about 55% below the five-year comparison base. Earnings and risk trends should explain the discount.

Current earnings relative to valuation equal about 6.4% on the 1/P/E measure. This is a valuation reference, not an expected payout.

Capital efficiency is characterized by ROE -51.2%, ROA -7.4%, ROCE 10.4%. Current return ratios are negative, materially weakening the fundamental profile.

On PEG (5.7x), valuation is stretched relative to growth and requires strong execution.

A longer cycle, from 276.5 days to 293.4 days, indicates slower release of cash from operations.

Conclusion

Compass Diversified's restrained price comes with modest current quality. Better efficiency is needed for revaluation.

Annual Financial Ratios Compass Diversified

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

P/E

-2.2 -7.3 15.6 -26.0 73.3 51.9 4.7 -155.6 36.3 17.5 5.1 2.9 12.8 -192.2 10.3 -10.4 - -

P/S

1.0 3.1 1.0 3.4 2.9 0.8 1.0 0.5 0.8 1.0 1.0 0.8 0.9 0.9 0.9 - - -

EPS

- -3.8 0.7 -1.4 - - - - - - - - - - -0.7 -1.6 -0.0 -

EV (Enterprise Value)

2.89 B 4.23 B 3.72 B 4.05 B 3.32 B 2.49 B 2.05 B 2.29 B 1.87 B 1.8 B 1.3 B 1.51 B 1.23 B 1.24 B 973 M 902 M -31.5 M -97.5 M

EBITDA per Share

2.51 1.65 0.85 1.3 2.5 2.87 2.46 2.29 1.61 1.45 1.49 1.82 2.47 2.07 1.11 -0.49 - -

EV/EBITDA

15.3 34.0 57.9 43.2 12.6 13.6 11.7 14.1 16.2 18.6 13.1 14.1 8.7 10.1 14.4 -50.0 -0.9 -

PEG

-0.21 -2.37 -1.09 -24.26 5.7 3.47 0.0 -34.23 -0.19 -0.22 -0.1 0.01 0.01 1.82 0.05 - - -

P/B

0.9 2.9 2.0 1.7 1.3 1.0 1.2 1.0 1.1 1.1 1.0 1.0 1.5 1.7 1.1 0.9 - -

P/CF

-71.7 -10.1 101.9 -33.0 12.1 8.0 28.7 13.8 27.4 11.0 12.2 14.3 16.7 22.3 9.7 11.3 - -

ROE %

-51.22 -30.78 11.69 -6.75 1.99 1.87 25.89 -0.62 3.02 6.11 18.53 34.50 11.96 -0.86 10.89 -9.99 -5.17 -

ROA %

-7.45 -6.33 3.27 -1.70 0.70 0.88 15.96 -0.24 1.54 3.08 11.35 18.02 6.51 -0.41 6.31 -4.95 - -

ROCE %

10.40 -2.74 -7.47 -2.52 3.56 6.39 5.53 3.28 2.77 2.81 3.85 3.96 9.82 8.30 3.07 -9.46 5.06 -

Current Ratio

1.2 1.2 1.3 1.4 1.7 1.9 3.1 2.6 2.5 2.2 2.5 2.3 3.1 2.4 3.0 2.4 - -

DSO

159.7 145.0 42.0 192.9 166.3 53.4 48.2 58.8 61.8 67.6 51.8 58.5 41.4 41.5 46.7 - - -

DIO

168.1 192.4 194.9 185.8 145.5 135.9 124.4 104.2 109.6 119.3 45.2 58.9 82.1 76.7 70.4 - - -

DPO

34.4 34.1 30.2 33.2 35.4 34.3 27.5 35.1 37.5 34.4 33.4 32.9 33.6 31.5 35.3 - - -

Operating Cycle

327.8 337.4 236.9 378.7 311.8 189.4 172.6 162.9 171.5 186.9 97.1 117.5 123.5 118.2 117.0 - - -

Cash Conversion Cycle

293.4 303.3 206.7 345.5 276.5 155.1 145.1 127.8 133.9 152.4 63.7 84.6 89.9 86.8 81.8 - - -

All numbers in USD currency

Quarterly Financial Ratios Compass Diversified

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

- - - - - - - - - - - - - - - - - - -0.08 0.97 -0.38 0.01 -0.06 0.08 -0.3 -0.26 -0.23 -1.3 3.38 1.72 -0.25 -0.07 -0.1 -0.09 0.53 0.1 -0.53 -0.6 -0.14 0.75 0.06 -0.31 -0.39 3.01 0.4 -0.47 0.14 5.15 0.11 0.08 -0.47 1.52 -0.01 0.03 - - - -0.02 - - - -0.14

EBITDA per Share

-0.05 0.46 -0.16 0.32 0.11 0.53 - 1.43 1.34 1.06 - 0.96 1.19 1.24 - 1.21 - 1.13 0.48 1.11 1.01 0.97 0.35 0.76 0.49 0.45 0.46 0.36 1.12 0.61 0.32 0.75 0.78 0.46 0.38 0.61 0.62 0.35 -0.2 0.66 0.47 0.43 0.3 0.57 0.5 0.35 0.02 0.3 0.58 0.48 0.05 2.1 0.56 0.61 0.09 0.68 0.66 0.5 -0.54 0.54 0.21 0.06

ROE %

-42.67 -36.49 -33.22 -25.39 -12.74 -4.36 0.05 -0.84 -1.47 8.81 8.94 8.79 11.63 12.29 3.62 5.60 13.11 9.76 9.68 8.46 2.85 3.49 2.07 1.65 -2.78 -4.51 4.96 3.78 7.02 9.42 -0.66 5.45 5.78 5.41 3.21 -1.86 3.06 5.78 6.39 5.91 20.02 20.73 19.59 20.82 34.93 32.71 36.33 34.03 15.51 14.65 14.38 14.10 -0.56 -0.42 -0.95 12.22 13.01 14.27 13.06 1.63 1.28 -1.40

ROA %

-7.59 -6.58 -6.44 -4.18 -2.40 -0.88 0.01 -0.26 -0.46 2.85 2.90 2.85 3.87 4.22 1.41 4.52 4.56 4.01 3.83 3.45 1.09 1.31 0.88 0.76 -1.28 -2.43 3.21 2.70 4.21 5.63 -0.24 2.59 2.81 2.63 1.54 -0.89 1.48 2.79 3.08 2.82 11.60 12.24 11.39 12.02 17.32 15.97 18.02 16.94 7.09 6.66 6.51 6.42 -0.24 -0.18 -0.41 5.87 6.29 6.90 6.31 0.79 0.62 -0.68

ROCE %

-9.05 -8.44 -7.45 -0.47 6.70 14.31 13.81 16.30 14.45 13.43 10.35 14.51 15.73 15.32 11.30 14.26 13.59 13.37 13.18 12.29 10.97 7.82 5.01 5.42 3.12 2.67 3.46 3.22 5.78 7.17 6.50 6.86 5.46 4.73 2.81 -1.05 -0.76 -0.08 2.23 5.48 5.92 6.41 6.04 4.20 3.20 3.37 4.16 4.50 22.55 23.78 25.96 26.53 12.62 13.86 12.98 6.64 3.53 0.78 -1.77 1.80 1.59 0.13

Current Ratio

1.2 1.2 1.2 1.1 1.1 1.2 1.2 1.6 1.6 1.6 1.7 1.6 1.6 1.6 1.6 1.6 - 1.7 1.7 1.7 1.8 1.6 1.9 1.9 1.9 1.9 2.6 2.0 2.6 2.6 1.6 1.6 1.8 1.6 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.6 2.6 2.6 2.6 2.1 2.1 2.1 2.1 2.2 2.2 2.2 2.2 1.9 1.9 1.9 1.9 2.4 2.4 2.4 2.4

DSO

20.1 20.3 24.9 42.6 39.3 40.6 - 60.4 58.6 57.1 - 51.8 54.2 55.4 - 24.9 23.5 48.5 45.6 45.8 50.1 50.2 45.5 55.8 74.1 67.4 48.7 48.5 52.0 53.5 50.6 60.6 72.2 53.7 61.6 60.6 63.9 62.4 - 65.5 77.2 67.8 - 54.4 52.2 57.5 - 89.2 53.4 49.9 - 38.4 41.5 40.1 - 38.1 39.9 39.6 - 37.4 57.7 -

DIO

131.6 181.8 - 208.0 203.4 207.1 - 264.1 262.7 247.0 - 230.1 246.5 223.7 - 92.4 92.7 174.3 - 134.7 119.5 139.7 - 135.2 153.3 145.2 - 117.7 42.3 130.0 - 117.3 - 110.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

28.4 33.6 - 41.0 36.6 36.0 - 28.2 28.5 28.4 - 27.6 26.8 25.4 - 12.8 14.0 32.0 - 31.0 29.8 36.9 - 36.9 42.9 36.6 - 28.6 9.3 30.6 - 34.9 - 33.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - 243.8 - - - 324.5 321.3 304.1 - 281.8 300.8 279.0 - 117.3 116.2 222.8 45.6 180.5 169.6 189.9 45.5 191.0 227.5 212.6 48.7 166.2 94.3 183.4 50.6 177.9 72.2 164.1 61.6 60.6 63.9 62.4 - 65.5 77.2 67.8 - 54.4 52.2 57.5 - 89.2 53.4 49.9 - 38.4 41.5 40.1 - 38.1 39.9 39.6 - 37.4 57.7 -

Cash Conversion Cycle

- - - 205.2 - - - 296.2 292.8 275.7 - 254.3 273.9 253.7 - 104.5 102.1 190.8 45.6 149.5 139.7 153.0 45.5 154.1 184.6 176.0 48.7 137.6 84.9 152.8 50.6 143.0 72.2 130.2 61.6 60.6 63.9 62.4 - 65.5 77.2 67.8 - 54.4 52.2 57.5 - 89.2 53.4 49.9 - 38.4 41.5 40.1 - 38.1 39.9 39.6 - 37.4 57.7 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Compass Diversified, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Conglomerates industry

Issuer Price % 24h Market Cap Country
Tejon Ranch Co. Tejon Ranch Co.
TRC
$ 16.04 -0.68 % $ 431 M usaUSA
Icahn Enterprises L.P. Icahn Enterprises L.P.
IEP
$ 6.15 -4.06 % $ 4.37 B usaUSA
India Globalization Capital India Globalization Capital
IGC
$ 0.24 -0.57 % $ 21.3 M usaUSA
SGOCO Group, Ltd. SGOCO Group, Ltd.
SGOC
- -0.32 % $ 718 M chinaChina
Cemtrex Cemtrex
CETX
$ 1.78 -1.11 % $ 236 K usaUSA
Alpha Metallurgical Resources Alpha Metallurgical Resources
AMR
$ 159.87 0.95 % $ 2.08 B usaUSA
Steel Partners Holdings L.P. Steel Partners Holdings L.P.
SPLP
- 0.57 % $ 756 M usaUSA
Matthews International Corporation Matthews International Corporation
MATW
$ 19.14 -1.44 % $ 595 M usaUSA
NN NN
NNBR
$ 3.47 -2.25 % $ 172 M usaUSA
Seaboard Corporation Seaboard Corporation
SEB
$ 3 775.27 -0.88 % $ 3.64 B usaUSA
Ocean Bio-Chem Ocean Bio-Chem
OBCI
- 0.04 % $ 123 M usaUSA